These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 18024321)
41. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma. Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626 [TBL] [Abstract][Full Text] [Related]
42. High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. Oudejans JJ; Harijadi H; Kummer JA; Tan IB; Bloemena E; Middeldorp JM; Bladergroen B; Dukers DF; Vos W; Meijer CJ J Pathol; 2002 Dec; 198(4):468-75. PubMed ID: 12434416 [TBL] [Abstract][Full Text] [Related]
43. The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck. Kim GE; Yang WI; Lee S; Kim YB; Suh CO; Yoon JH; Oh YT; Chung HC; Kim BS Cancer; 2001 Jun; 91(12):2343-52. PubMed ID: 11413524 [TBL] [Abstract][Full Text] [Related]
44. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105 [TBL] [Abstract][Full Text] [Related]
45. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540 [TBL] [Abstract][Full Text] [Related]
46. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581 [TBL] [Abstract][Full Text] [Related]
47. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis. Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607 [TBL] [Abstract][Full Text] [Related]
48. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma. Wang F; Jing X; Li G; Wang T; Yang B; Zhu Z; Gao Y; Zhang Q; Yang Y; Wang Y; Wang P; Du Z Liver Int; 2012 Apr; 32(4):644-55. PubMed ID: 22118340 [TBL] [Abstract][Full Text] [Related]
49. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages. Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089 [TBL] [Abstract][Full Text] [Related]
50. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Oudejans JJ; Jiwa NM; Kummer JA; Ossenkoppele GJ; van Heerde P; Baars JW; Kluin PM; Kluin-Nelemans JC; van Diest PJ; Middeldorp JM; Meijer CJ Blood; 1997 Feb; 89(4):1376-82. PubMed ID: 9028961 [TBL] [Abstract][Full Text] [Related]
51. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Mahmoud SM; Paish EC; Powe DG; Macmillan RD; Lee AH; Ellis IO; Green AR Breast Cancer Res Treat; 2011 May; 127(1):99-108. PubMed ID: 20556505 [TBL] [Abstract][Full Text] [Related]
52. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941 [TBL] [Abstract][Full Text] [Related]
53. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383 [TBL] [Abstract][Full Text] [Related]
54. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients. Alvaro-Naranjo T; Lejeune M; Salvadó-Usach MT; Bosch-Príncep R; Reverter-Branchat G; Jaén-Martínez J; Pons-Ferré LE Leuk Lymphoma; 2005 Nov; 46(11):1581-91. PubMed ID: 16236613 [TBL] [Abstract][Full Text] [Related]
55. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Kobayashi N; Hiraoka N; Yamagami W; Ojima H; Kanai Y; Kosuge T; Nakajima A; Hirohashi S Clin Cancer Res; 2007 Feb; 13(3):902-11. PubMed ID: 17289884 [TBL] [Abstract][Full Text] [Related]
56. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas. Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127 [TBL] [Abstract][Full Text] [Related]
57. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma. Tzankov A; Matter MS; Dirnhofer S Pathobiology; 2010; 77(6):301-8. PubMed ID: 21266828 [TBL] [Abstract][Full Text] [Related]
58. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma. Dinand V; Malik A; Unni R; Arya LS; Pandey RM; Dawar R Pediatr Blood Cancer; 2008 Feb; 50(2):280-3. PubMed ID: 17417795 [TBL] [Abstract][Full Text] [Related]
59. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma. Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234 [TBL] [Abstract][Full Text] [Related]
60. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]